Phase 4
Completed N=13
Assessment of Alcon's Ocular Image Quantification System
Source: ClinicalTrials.gov NCT01282138 ↗Enrolled (actual)
13
Serious AEs
0.0%
Results posted
Jul 2012
Primary outcomePrimary: Change From Baseline in Patient-Assessed Ocular Itching, Environmental Exposure Chamber (EEC), at 3 Hours — -1.63; -1.11 Units on a scale
Summary
The purpose of this study was to evaluate ocular responses with different allergen provocation methods.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change From Baseline in Patient-Assessed Ocular Itching, Environmental Exposure Chamber (EEC), at 3 Hours |
-1.63; -1.11 | — |
| PRIMARY Change From Baseline in Patient-Assessed Ocular Itching, Conjunctival Allergen Provocation Test (CAPT), at 3 Hours |
-0.38; -1.15 | — |
Eligibility Criteria
Inclusion Criteria
- History of allergic conjunctivitis;
- Active signs and symptoms of ocular allergies;
- Other protocol-defined inclusion criteria may apply.
Exclusion Criteria
- History of dry eye;
- Presence of ocular infection;
- Presence of severe or serious ocular conditions;
- Symptoms of allergic conjunctivitis;
- Use of topical or systemic ocular medications as specified in protocol;
- Ocular surgery or laser surgery within 6 months of study start;
- Unwilling to discontinue contact lens wear 72 hours prior to Visit 1 and during study period;
- Other protocol-defined exclusion criteria may apply.
Data sourced from ClinicalTrials.gov (NCT01282138). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.